Latest News

  • 23andMe Therapeutics Won't Change Drug Discovery

    But it's a good move from a company that should know better than anyone how to turn genetic data into real value.  By Aaron Krol  March 17, 2015 | For as long as 23andMe has been in business, observers have

    May 14, 2015
  • Diagnostic-Maker Scanadu Lands $35M As FDA Submission Nears

    Xconomy | Scanadu, a Mountain View, CA based startup that's making a diagnostic device it likens to Star Trek's famous Tricorders, has received $35 million of Series B funding.

    May 27, 2015
  • IBM Sees Opportunities in Care Management with Watson Health

    Computerworld | After years of experiments using its Watson cognitive computing technology in medical settings, IBM announced this week the creation of a Watson Health business unit that will provide new capabilities in intelligent monitoring of patients' health data.

    May 27, 2015
  • GigaScience Paper Demonstrates Pathogen Detection on the MinION

    Diagnostics World Brief | A team of researchers led by Andy Kilianski of Maryland’s Edgewood Chemical Biological Center has published a paper demonstrating the use of the MinION nanopore sequencer to accurately identify strains of bacteria and viruses. 

    May 27, 2015
  • The Right Drug the First Time

    Diagnostics World Brief | Scientists in the growing field of pharmacogenetics believe that new DNA tests can protect patients from adverse drug responses and ineffective prescriptions. Yet it's been an uphill battle to convince payers, medical centers, and clinicians to embrace these tests in mainstream medicine.

    May 27, 2015